APUS:Apimeds Pharmaceuticals US Inc Snapshot | Charting | News | Options
$1.95   0.00%  $0.00 NYSE MKT LLC 7:00a ET
March 25 '26 		Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceutical... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
     GlobeNewswire
    Full Story →

    Headline News
    More News →
    Day  0.00%Week  0.00%Month  3.72%More Charting →
    May 6 '26. Markets Closed.
    Last $1.95
    Day change   0.00%$0.00
    Open $NA
    Gap at open $NA
    Previous close $1.95
    Trading volume 2,794
    10 Day avg vol. 3,029,362
    Shares out. 12.6Mil
    Market cap. $24.5Mil
    Trading activity Below Avg.
    Previous data from yesterday, May 6 '26.

    Historical Price Performance
    3 month   20.37% 
    6 month   12.56% 
    1 year   NA 
    2 year   NA 
    NA = Not Available

    Earnings
    Previous 12m -$4.76
    Next 12m Estimate NM
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.